Association of biological antirheumatic therapy with risk for type 2 diabetes: a retrospective cohort study in incident rheumatoid arthritis

Association of biological antirheumatic therapy with risk for type 2 diabetes: a retrospective cohort study in incident rheumatoid arthritis

Objective To explore possible associations of treatment with biological disease-modifying antirheumatic drugs (bDMARDs), including T-cell-based and interleukin-6 inhibition (IL-6i)-based therapies, and the risk for type 2 diabetes mellitus (T2DM) in patients with rheumatoid arthritis (RA).Study desi...

Full description

Saved in:
Bibliographic Details
Main Authors: Attila Pethö-Schramm, Sara Gale, Khaled Sarsour, Sanjoy K Paul, Olga Montvida, Jennie H Best
Format: Article
Language:English
Published: BMJ Publishing Group 2021-06-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/11/6/e042246.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items